107 related articles for article (PubMed ID: 17328497)
1. Cytokeratin 8 and 18 expression in imprint smears of chronic viral hepatitis, autoimmune hepatitis and hepatocellular carcinoma. A preliminary study.
Athanassiadou P; Psyhoyiou H; Grapsa D; Gonidi M; Ketikoglou I; Patsouris E
Acta Cytol; 2007; 51(1):61-5. PubMed ID: 17328497
[TBL] [Abstract][Full Text] [Related]
2. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis.
Murota M; Nishioka M; Fujita J; Dobashi N; Wu F; Ohtsuki Y; Hojo S; Takahara J; Kuriyama S
Clin Exp Immunol; 2001 Aug; 125(2):291-9. PubMed ID: 11529922
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
[TBL] [Abstract][Full Text] [Related]
5. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
6. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
[No Abstract] [Full Text] [Related]
7. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies on cytokeratin 8 and 18 expressions in canine cutaneous adnexus and their tumors.
Kato K; Uchida K; Nibe K; Tateyama S
J Vet Med Sci; 2007 Mar; 69(3):233-9. PubMed ID: 17409637
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratins 8 and 18 in adult human corneal endothelium.
Merjava S; Neuwirth A; Mandys V; Jirsova K
Exp Eye Res; 2009 Sep; 89(3):426-31. PubMed ID: 19409893
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 8 is increased in hepatitis C virus cells and its ectopic expression induces apoptosis of SMMC7721 cells.
Sun MZ; Dang SS; Wang WJ; Jia XL; Zhai S; Zhang X; Li M; Li YP; Xun M
World J Gastroenterol; 2013 Oct; 19(37):6178-87. PubMed ID: 24115814
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas.
Kakehashi A; Inoue M; Wei M; Fukushima S; Wanibuchi H
Toxicol Appl Pharmacol; 2009 Jul; 238(1):71-9. PubMed ID: 19409407
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas.
Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B
Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506
[TBL] [Abstract][Full Text] [Related]
14. Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).
Han CP; Hsu JD; Koo CL; Yang SF
Hum Pathol; 2010 Apr; 41(4):616-7; author reply 617. PubMed ID: 20226963
[No Abstract] [Full Text] [Related]
15. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus.
Makino T; Yamasaki M; Takeno A; Shirakawa M; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Matsuura N; Mori M; Doki Y
Br J Cancer; 2009 Oct; 101(8):1298-306. PubMed ID: 19755983
[TBL] [Abstract][Full Text] [Related]
16. sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology.
Tortorella C; Sacco R; Orlando P; Salerno MT; Schiraldi O; Antonaci S
Immunopharmacol Immunotoxicol; 2000 Feb; 22(1):19-33. PubMed ID: 10737254
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 8 and 18 tissue expression in gallbladder mucosa of patients with cholelithiasis.
Kasprzak A; Malkowski W; Seraszek A; Surdyk-Zasada J; Szmeja J; Rogacki K; Kaczmarek E; Zabel M
Pol J Pathol; 2011 Dec; 62(4):241-9. PubMed ID: 22246910
[TBL] [Abstract][Full Text] [Related]
18. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.
Murata A; Genda T; Ichida T; Amano N; Sato S; Tsuzura H; Sato S; Narita Y; Kanemitsu Y; Shimada Y; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
World J Gastroenterol; 2016 Sep; 22(33):7569-78. PubMed ID: 27672277
[TBL] [Abstract][Full Text] [Related]
20. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
